SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2207Any thoughts on earnings coming and recent beat down? Ang2/Eylea should read ouFelix B-10/25/2017
2206A short term and longer term view of REGN, the HHS collaboration, and then a parBiotech Jim110/2/2017
2205I think that their bi-specific is not very alive, toooooo slowwwwwww!Miljenko Zuanic-9/14/2017
2204Sometime before it reads out right? Also they haven't made much publicity oFelix B-9/12/2017
2203<We need the oncology efforts to become more visible.> In time! In time? Miljenko Zuanic-9/11/2017
2202I agree with your points, but the market is fickle! We need the oncology effoBiotech Jim-9/11/2017
2201<Down to the $350- 375 area?> No, I do not think so! Praluent IP will preMiljenko Zuanic-9/11/2017
2200Competition is the name of the game. <So, severe correction is...???????? ..Biotech Jim-9/11/2017
2199Surprice???!!! finance.yahoo.com So, what trigger SNY rush for more REGN sharesMiljenko Zuanic-9/11/2017
2198Yes, it is distraction for investors.Miljenko Zuanic-9/7/2017
2197And should come in cheaper due to not being a biologic right?Felix B-9/7/2017
2196Possibility of REGN getting this too? I would imagine most practitioners would Felix B-9/7/2017
2195Very comparative to Dupi (in AD): prnewswire.comMiljenko Zuanic-9/7/2017
2194Anyone have access to this? statnews.comFelix B-8/31/2017
2193Right in time with CAR-T approval: roche.comMiljenko Zuanic-8/30/2017
2192Another question: When antibody R&D end, can Sanofi lunch hostile take-over?Miljenko Zuanic-8/29/2017
2191And again today (70 K shares): secfilings.nasdaq.com Does ability to reach 30% Miljenko Zuanic-8/29/2017
2190What is now this rush at Sanofi, 164.5 K shares (~$78-80 M), in two days: secfiMiljenko Zuanic-8/25/2017
2189Praluent may stay on market, but MACE outcome trial has reduced chances to be siMiljenko Zuanic-8/23/2017
2188Not sure what is worst, Montley or Seeking Alpha, then again where else do I go?Felix B-8/22/2017
2187What's your guess on litigation outcome of Praulent? I think everyone has cFelix B-8/22/2017
2186fool.com Idiots at Motley Fool have nothing better to talk, that the Street &quMiljenko Zuanic-8/22/2017
2185Well, Eliquis is eliquis, bit of unick. RE: Dupi pharmpro.com I do not know whaMiljenko Zuanic-8/22/2017
2184Thanks for sharingFelix B-8/9/2017
2183More colour (review): epvantage.comMiljenko Zuanic-8/9/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News